Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CASP3 | P42574 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | GLS | O94925 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.36 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329301 | 0.78 | DRD3 (0.43) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL2183011 | 0.78 | CASP3 (0.40) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL8860266 | 0.75 | CASP3 (0.46) | ALDH1A1CASP3CA12CA9POLB | |
| SCHEMBL5177139 | 0.75 | DRD3 (0.44) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL30124938 | 0.75 | ALDH1A1 (0.48) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL29372938 | 0.75 | ALDH1A1 (0.48) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL35297 | 0.75 | ALDH1A1 (0.48) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL20954062 | 0.74 | POLB (0.46) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL30996374 | 0.72 | POLB (0.44) | ALDH1A1CASP3CA12CA9GLS | |
| SCHEMBL238005 | 0.72 | POLB (0.44) | ALDH1A1CASP3CA12CA9GLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070197791-A1 | Method for the preparation of dicarboxylic lmides | SIEGFRIED LTD. (CH) | 2007-08-23 | — | — | US | claimed |
| US-20070173647-A1 | Method for the preparation of dicarboxylic imides | SIEGFRIED LTD. (CH) | 2007-07-26 | — | — | US | claimed |
| EP-1810964-A1 | Process for the preparation of dicarboxylic acid imides | Siegfried Ltd. (CH) | 2007-07-25 | — | — | EP | claimed |
| US-20070197791-A1 | Method for the preparation of dicarboxylic lmides | SIEGFRIED LTD. (CH) | 2007-08-23 | — | — | US | disclosed |
| US-20070173647-A1 | Method for the preparation of dicarboxylic imides | SIEGFRIED LTD. (CH) | 2007-07-26 | — | — | US | disclosed |
| EP-1810964-A1 | Process for the preparation of dicarboxylic acid imides | Siegfried Ltd. (CH) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173647-A1 | Method for the preparation of dicarboxylic imides | RCOR3, NR2E3, FGFR3 | ALDH1A1 1880/4885CASP3 608/4885CA12 204/4885 |
| US-20070197791-A1 | Method for the preparation of dicarboxylic lmides | RPL3, CCNH, CCNB3 | ALDH1A1 2533/4885CASP3 569/4885CA12 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.